基本信息
浏览量:0
职业迁徙
个人简介
暂无内容
研究兴趣
论文共 26 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
FRONTIERS IN IMMUNOLOGY (2024)
Hitoshi Kawasuji,Yoshitomo Morinaga,Hideki Tani,Hiroshi Yamada,Yoshihiro Yoshida, Masayoshi Ezaki, Yuki Koshiyama,Yusuke Takegoshi,Makito Kaneda,Yushi Murai,Kou Kimoto,Kentaro Nagaoka,Hideki Niimi,Yoshihiro Yamamoto
VACCINEno. 22 (2024)
Shigeru Azuma,Hitoshi Kawasuji,Ryosuke Nakai,Hiroshi Yamada,Yoshihiro Yoshida,Hiroyuki Kawahara,Mai Suzuki, Shunsuke Mori,Masayoshi Hirata, Kazushige Sugie,Hideki Niimi,Yoshitomo Morinaga,Yoshihiro Yamamoto
Journal of infection and chemotherapy (2024)
Hisashi Tamaki,Kenji Baba, Toshiyuki Ono, Ltd Hitachi, Akira Senga, Tepco Power Grid, Inc Kawauchi,Takashi Hirano, Nec Corp, S. Kitamura,Hiroyuki Nishikawa,Keita Tanaka,Yasue Mitsukura, Yusuke Watabe, Meidensha Corp, Masaaki Miyashita, Makoto Criepi,Tatsuya Nakae,Takuya Sato, Fujitsu Ltd,Kenta Fujimoto, Tsutomu Inamoto, Kozo Banno,Nobuhiko Nakano, Atsushi Fukumoto, K. Mori,Hiroshi Yamada,Chikahito Nakajima, Chiri Yamaguchi, Kensuke Kuraki, Toshiyuki Chairperson, Hirooki Aoki,Takashi Okamoto, Sensy Co, Ltd Kaihara, Yukio Goto, Toshimasa Harada,Katsutoshi Saeki,Masahiro Kurono, Takafumi Criepi, Takashi Fukumoto, Hitachi Ltd, Seiichi Koakutsu, Hiroshi Nakatani,Yasushi Ono
IEEJ Transactions on Electronics Information and Systemsno. 5 (2024): L5_1-L5_1
medrxiv(2022)
Tatsuhiko Ozawa,Hideki Tani,Yuki Anraku,Shunsuke Kita,Emiko Igarashi,Yumiko Saga,Noriko Inasaki,Hitoshi Kawasuji,Hiroshi Yamada,So-Ichiro Sasaki,Mayu Somekawa,Jiei Sasaki,Yoshihiro Hayakawa,Yoshihiro Yamamoto,Yoshitomo Morinaga,Nobuyuki Kurosawa,Masaharu Isobe,Hideo Fukuhara,Katsumi Maenaka,Takao Hashiguchi,Hiroyuki Kishi,Isao Kitajima,Shigeru Saito,Hideki Niimi
Scientific Reportsno. 1 (2022): 1-1
SCIENTIFIC REPORTSno. 1 (2022)
加载更多
作者统计
#Papers: 27
#Citation: 218
H-Index: 6
G-Index: 14
Sociability: 5
Diversity: 2
Activity: 26
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn